Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.news-medical.net/news/20230615/Phase-3-clinical-trial-shows-favorable-safety-and-immunogenicity-profile-of-single-shot-live-attenuated-chikungunya-vaccine.aspx
0
0
Phase 3 clinical trial shows favorable safety and immunogenicity profile of single-shot live-attenuated chikungunya vaccine - News-Medical.Net
+ 112 more
6/15/23 at 1:57pm
Organization
News-Medical.Net
Authors
Details
29 words
Summarize
Infectious Diseases
Health
Public Health
Medical Procedures
Public Safety
Researchers performed a double-blinded, phase III randomized trial.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...